Skip to main navigation
Skip to search
Skip to main content
University of Copenhagen Research Portal Home
Help & FAQ
Dansk
English
Home
Profiles
Research output
Research units
Press/Media
Activities
Prizes
???studenttheses???
Datasets
Search by expertise, name or affiliation
Antioxidant supplementation for lung disease in cystic fibrosis
Oana Ciofu
,
Jens Lykkesfeldt
Lifepharm
20
Citations (Scopus)
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Antioxidant supplementation for lung disease in cystic fibrosis'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Cystic Fibrosis
100%
Lung Disease
100%
Antioxidant Supplementation
100%
Confidence Interval
88%
Glutathione
44%
Antioxidant
44%
Vitamin E
44%
Oxidative Stress
44%
Lung Function
33%
Randomized Controlled Study
33%
Vitamin C
22%
Forced Expiratory Volume
22%
Selenium
22%
Carotene
22%
Nutritional Status
22%
Oral nutritional Supplements
22%
Quality of Life
22%
Single Administration
11%
Cochrane
11%
Oxidative Status
11%
Blood Levels
11%
Life Data
11%
Etiology
11%
Inhalation
11%
Existing Knowledge
11%
Conflicting Evidence
11%
Clinically Meaningful Outcomes
11%
Large Population
11%
Adverse Events
11%
Population Sample
11%
Quality of Life Improvement
11%
Extracted Data
11%
Dietary Vitamin E
11%
Beneficial Effects
11%
Biological Pathways
11%
Genetic Disease
11%
Mean Group
11%
Forced Vital Capacity
11%
PubMed
11%
Airway Infection
11%
Placebo
11%
Route of Administration
11%
Risk of Bias
11%
Means of Control
11%
Search Strategy
11%
Antibiotics
11%
Progressive Damage
11%
Chronic Infection
11%
No Significant Difference
11%
Lung
11%
Clinical Efficacy
11%
Body Mass Index
11%
Cystic Fibrosis Lung Disease
11%
Antibiotic Treatment
11%
Inflammation
11%
Dose Level
11%
Well-being
11%
Medicine and Dentistry
Silo-Filler's Disease
100%
Supplementation
100%
Cystic Fibrosis
100%
Antioxidant
100%
Glutathione
60%
Lung
40%
Alpha Tocopherol
40%
Oxidative Stress
40%
Quality of Life
30%
Ascorbic Acid
20%
Carotene
20%
Forced Expiratory Volume
20%
Nutritional Status
20%
Antibiotic Therapy
10%
Respiratory Tract Infection
10%
Body Mass Index
10%
Adverse Event
10%
Single Drug Dose
10%
Genetic Disorder
10%
Exhalation
10%
Infection
10%
Placebo
10%
Antibiotics
10%
Oxidizing Agent
10%
Trace Element
10%
Forced Vital Capacity
10%
Nursing and Health Professions
Lung Disease
100%
Antioxidant
100%
Supplementation
100%
Cystic Fibrosis
100%
Confidence Interval
80%
Alpha Tocopherol
40%
Quality of Life
30%
Ascorbic Acid
20%
Nutritional Status
20%
Forced Expiratory Volume
20%
Single Drug Dose
10%
Genetic Disorder
10%
Respiratory Tract Infection
10%
Body Mass
10%
Forced Vital Capacity
10%
Infection
10%
Inflammation
10%
Antibiotic Therapy
10%
Trace Element
10%
Blood Level
10%
Adverse Event
10%
Medline
10%
Placebo
10%